about
Multiple genes coding for precursors of rhodotorucine A, a farnesyl peptide mating pheromone of the basidiomycetous yeast Rhodosporidium toruloidesDiurnal rhythm of rat liver cytosolic 3-hydroxy-3-methylglutaryl-CoA synthaseInhibition by etomoxir of rat liver carnitine octanoyltransferase is produced through the co-ordinate interaction with two histidine residuesNatural trans-splicing in carnitine octanoyltransferase pre-mRNAs in rat liverImmunohistochemical evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer disease.Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormoneSite-specific antibodies against the PrlA (secY) protein of Escherichia coli inhibit protein export by interfering with plasma membrane binding of preproteins.Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus.The v-sis/PDGF-2 transforming gene product localizes to cell membranes but is not a secretory protein.Regulation of ribosomal protein S25 in HL60 cells isolated for resistance to adriamycin.Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodologyEffects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes.Histones: at the crossroads of peptide and protein chemistry.Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogenPlasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha 1-proteinase inhibitorBiological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics.Cyclotides, a novel ultrastable polypeptide scaffold for drug discoveryA mycoplasma high-affinity transport system and the in vitro invasiveness of mouse sarcoma cellsUse of antipeptide antibodies to demonstrate external orientation of the NH2-terminus of the low density lipoprotein receptor in the plasma membrane of fibroblasts.T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR moleculesDetection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus.Antigen recognition and the immune response. Humoral and cellular immune responses to small mono- and bifunctional antigen molecules.Antigen recognition and the immune response. "Self-help" with symmetrical bifunctional antigen molecules.Antigen structural requirements for immunoglobulin isotype switching in mice.Chemical and biological production of cyclotides.Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppressionStructure of the hepatitis A virion: peptide mapping of the capsid region.Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs.Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen.Alternative protein products with different carboxyl termini from a single class I gene, H-2Kb.Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically relatedIntramolecular dislocation of the COOH terminus of the lac carrier protein in reconstituted proteoliposomes.Antibodies of predetermined specificity for the NH2 terminus of a cellular protein p53 react with the native molecule: evidence for the presence of different p53s.Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodiesCyclotides: Overview and Biotechnological Applications.Spatial requirements between haptenic and carrier determinants for T-dependent antibody responsesDevelopment of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiencyA poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1.
P2860
Q28257850-18968CEA-78E1-4B67-88EB-DF07216B9E48Q28580268-D1B9A4EE-07F1-4E65-8602-2052A68F8919Q28581761-A1249110-23B7-4C9F-BC83-3F49BC19CF9FQ32000542-A9EBFEAF-CFD4-4B87-B51E-386F12266224Q33567803-29FAA0E9-6F19-4F1A-B71C-7D3FEE9A846BQ33577418-38C87486-3B0D-4872-9641-1D47593779D5Q33843679-489708F5-EC46-4A50-9D45-8688EC76FA90Q33926692-99BC590F-A542-43C2-BDB9-2F4BFBD27FDDQ33931532-800032FD-F50C-400A-9E66-4E2181FB5352Q34352798-9D44E121-E312-47AD-A14F-2E41C00A4F68Q34567715-6E5BF1DE-F1B6-4C7C-A849-11B07457C470Q35101392-5A92F861-3B47-4EE8-948E-52B4A1A3F12DQ35229609-883383C5-0385-4A27-A826-BDE13BAE0F3BQ35373888-D538E752-294B-4237-ACFD-5799D0B29355Q35593333-CF401F22-E369-4904-8AE7-D7E66F9EAEC0Q35598861-BDA6AF28-1E0A-4160-8704-BC4FF3187080Q35893500-22F9A58D-498C-4829-A6AC-13B802DF8298Q35900582-9C2B5542-0380-4CAC-9B77-E325C054AE6DQ35997059-300A3FDF-890A-450D-857A-C294F8B0415BQ36208347-DAF6A958-D508-4444-A17B-3D6D1B27CCC7Q36231401-5228DCA0-A131-4CC6-B7C5-208AC9112180Q36249895-0C7D2856-728D-4C6D-B8EF-7C4B9AD99084Q36271604-21FB0B3F-927D-4BAC-9C97-59421BAAFB81Q36272216-464F13D7-6AE5-420E-9FC0-4E9FACB102FCQ36344303-4CD0FDA1-A7E7-408C-92CC-C925AEC83FA2Q36771109-A671406A-A62E-47E2-8ADF-3C28B9B13549Q36825746-5B189876-2BE5-4F71-AE3B-AA8C061A1BA1Q36861971-94FC31B4-D3A9-4F83-AF45-F13677D33D79Q36883657-EED806E8-A9F7-42B6-9252-13F1BD721F1CQ37345629-ECF05B1E-1BF4-4F2A-A011-A09216F3BA5CQ37393021-6F9D9BA1-5879-45BD-B6FC-6D0AA181122CQ37395430-DBCD3D3B-1577-4B44-8833-5866968B832BQ37558902-0F3BDEA4-409F-4244-BBF9-C226E2451B58Q37560344-5791CEB7-2F59-4D23-A80F-3EF130A147FEQ37604788-5C1220BB-4538-48B9-B313-4798BE120755Q37677273-BBA27896-4739-4336-B069-FF82E441BBA7Q39330201-8434991C-5AC1-4FB4-99B8-B3392D998868Q39511391-61610F37-F636-4498-8A70-A3954B147DABQ40510653-EB822690-0901-401D-8525-091B83CD179BQ41464907-968321CF-28E3-407A-AB68-9B5FBE74A8D8
P2860
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh
1970年學術文章
@zh-hant
name
Chemical synthesis of peptides and proteins.
@en
Chemical synthesis of peptides and proteins.
@nl
type
label
Chemical synthesis of peptides and proteins.
@en
Chemical synthesis of peptides and proteins.
@nl
prefLabel
Chemical synthesis of peptides and proteins.
@en
Chemical synthesis of peptides and proteins.
@nl
P1476
Chemical synthesis of peptides and proteins.
@en
P2093
Merrifield RB
P304
P356
10.1146/ANNUREV.BI.39.070170.004205
P577
1970-01-01T00:00:00Z